Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Jiri Ferda"'
Autor:
Jiri Molacek, Vladislav Treska, Tomas Skalicky, Josef Vodicka, Jiri Ferda, Eva Ferdova, Jan Baxa, Christiana Mach, Alexandra Jungova, Michael Michal
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundCastleman´s disease is an extremely rare heterogenous lymphoproliferative pathology with a mostly benign behavior. It is a localized or generalized lymph node enlargement of an unknown aetiology. Unicentric form is typically a slow-growing
Externí odkaz:
https://doaj.org/article/d976299f467d48eda88f9cd9e4e0bc31
Autor:
Thomas W. Georgi, Dietrich Stoevesandt, Lars Kurch, Jörg M. Bartelt, Dirk Hasenclever, Helmut Dittmann, Jiri Ferda, Peter Francis, Christiane Franzius, Christian Furth, Daniel Gräfe, Alexander Gussew, Martin Hüllner, Leon J. Menezes, Mona Mustafa, Lars Stegger, Lale Umutlu, Klaus Zöphel, Pietro Zucchetta, Dieter Körholz, Osama Sabri, Christine Mauz-Körholz, Regine Kluge
Publikováno v:
J Nucl Med
(18)F-FDG PET/MRI might be the diagnostic method of choice for Hodgkin lymphoma patients, as it combines significant metabolic information from PET with excellent soft-tissue contrast from MRI and avoids radiation exposure from CT. However, a major i
Autor:
ONDREJ FIALA, JAN BAXA, MARTIN SVATON, LUCIE BENESOVA, RENATA PTACKOVA, TEREZA HALKOVA, MAREK MINARIK, PETR HOSEK, MARCELA BURESOVA, JINDRICH FINEK, JIRI FERDA, MILOS PESEK
Publikováno v:
Cancer Genomics - Proteomics. 19:270-281
Autor:
Martin Petersilka, Thomas Flohr, Stefan Ulzheimer, Andre Henning, Bernhard Schmidt, Jiri Ferda
Publikováno v:
Physica Medica. 79:126-136
Photon-counting detectors are a promising new technology for computed tomography (CT) systems. They provide energy-resolved CT data at very high spatial resolution without electronic noise and with improved tissue contrasts. This review article gives
Autor:
Martin Sedlmair, Jiri Ferda, Martin Svatoň, Jan Baxa, Thomas Flohr, Miloš Pešek, Jaroslav Ludvik, Bernhard Schmidt, Petr Hosek
Publikováno v:
Anticancer Research. 40:3459-3468
AIM To compare iodine-related and fluorine-18 fluorodeoxyglucose (18F-FDG) parameters during staging of lung cancer as well as during early follow-up, while investigating potential use and possible substitutability in the assessment of therapeutic re
Autor:
Ondrej, Fiala, Jan, Baxa, Martin, Svaton, Lucie, Benesova, Renata, Ptackova, Tereza, Halkova, Marek, Minarik, Petr, Hosek, Marcela, Buresova, Jindrich, Finek, Jiri, Ferda, Milos, Pesek
Publikováno v:
Cancer Genomics Proteomics
Background/Aim: Circulating tumour DNA (ctDNA) represents an emerging biomarker in non-small cell lung cancer (NSCLC). We focused on the combination of ctDNA and positron emission tomography/computed tomography (PET/CT) in the follow-up monitoring of
Autor:
Vaclav Liska, Skalicky T, Radek Kucera, Jiri Ferda, Daniel Lysák, Jakub Fichtl, Inka Treskova, Jan Bruha, Vladislav Treska, Jaroslav Ludvik, Ondrej Topolcan
Publikováno v:
Anticancer Research. 38:5531-5537
BACKGROUND Portal vein embolization (PVE) and PVE with autologous mesenchymal stem cell application (PVE-MSC) increases future liver remnant volume (FLRV). The aim of this study was to compare both methods from the aspect of FLRV growth, progression
Autor:
Jiri Bejcek, Martin Sedlmair, Jaroslav Ludvik, Miloš Pešek, Thomas Flohr, Bernhard Schmidt, Tana Matouskova, Jan Baxa, Jiri Ferda
Publikováno v:
Anticancer Research. 38:4131-4137
Aim: The aim of the study was to assess possible correlation of fluorogeoxyglucose (FDG) uptake and iodine-related attenuation values derived from positron-emission tomography/computed tomography (PET/CT) using single-source dual-energy CT scan (DE-C
Publikováno v:
In Vivo. 31:763-767
Background/aim Hepatic epithelioid haemangio-endothelioma (HEHE) is a very rare malignant tumor of vascular origin and uncertain biological behaviour that is difficult to diagnose using preoperative radiology diagnostic techniques. Patients and metho
Autor:
Monika Ulamec, Ondrej Daum, Kristyna Pivovarcikova, Milan Hora, Delia Perez Montiel, Petr Martinek, Tomas Vanecek, Ondrej Hes, Michal Michal, Magdalena Dubova, Ondrej Ondič, Jiri Ferda, Kristyna Prochazkova, Kvetoslava Peckova, Pavla Rotterova, Whitney Davidson, Faruk Skenderi, Reza Alaghehbandan
Publikováno v:
Annals of Diagnostic Pathology. 26:23-30
Conflicting data have been published on the prognostic significance of tumor necrosis in papillary renal cell carcinoma (PRCC). Although the presence of necrosis is generally considered an adverse prognostic feature in PRCC, we report a cohort of 10